Skip links
Companies
› United Kingdom › JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
JAZZ PHARMACEUTICALS RESEARCH UK LIMITED logo

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

Private limited company (Ltd.) Active

Registration No.
03107561
Incorporation Date
1995-09-28
Company Type
Private limited company (Ltd.)
Address
Sittingbourne, United Kingdom
Website
www.jazzpharma.com/
Source: Companies House

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED is a Private limited company (Ltd.) registered in United Kingdom under 03107561, and its current status with Companies House is active. The company was incorporated on 28 September 1995 and lists its registered address as Sittingbourne, United Kingdom. 1 shareholder is on record for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Companies House and was last updated on 19 October 2026.

Data Provenance
This record is sourced directly from official government registries, including Companies House.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

One shareholder is currently on record for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006.

The largest of these is GW PHARMACEUTICALS LTD, holding 100% — a majority holding.

Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
GW PHARMACEUTICALS LTD 100% Companies House

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

4

Four officers are currently on record for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED, filed with Companies House. David Spackman (appointed 2023-01-13), Luca Marchetti (appointed 2023-04-28) and Jessica Petersen (appointed 2024-10-01) all serve as Director; Alkesh Patel (appointed 2024-04-03) serves as Company Secretary.

The register reports 26 officers in total, including past appointments, though only the 4 most relevant records are shown here.

Management authority at JAZZ PHARMACEUTICALS RESEARCH UK LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

DS
David Spackman ACTIVE

Appointed
2023-01-13
Residence
🇬🇧 United Kingdom
Occupation
Director

LM
Luca Marchetti ACTIVE

Appointed
2023-04-28
Residence
🇬🇧 United Kingdom
Occupation
Director

JP
Jessica Petersen ACTIVE

Appointed
2024-10-01
Residence
🇬🇧 United Kingdom
Occupation
Director

AP
Alkesh Patel ACTIVE

Appointed
2024-04-03
Residence
🇬🇧 United Kingdom
Occupation
Company Secretary

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED sits 3 levels below its ultimate parent, JAZZ INVESTMENTS EUROPE LIMITED, registered in Malta. The full chain up to JAZZ INVESTMENTS EUROPE LIMITED is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's own shareholder record.

Ultimate HQ
JAZZ INVESTMENTS EUROPE LIMITED
Malta

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on JAZZ PHARMACEUTICALS RESEARCH UK LIMITED?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns JAZZ PHARMACEUTICALS RESEARCH UK LIMITED?

One shareholder is currently on record for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED, held on the Confirmation Statement (CS01), filed under the Companies Act 2006. The largest of these is GW PHARMACEUTICALS LTD, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does JAZZ PHARMACEUTICALS RESEARCH UK LIMITED have on record?

1 shareholder is shown on record for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED.

What is JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's company registration number?

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's registration number is 03107561, filed with Companies House in United Kingdom. Its current status on the register is active.

Is JAZZ PHARMACEUTICALS RESEARCH UK LIMITED still an active company?

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's status on Companies House is listed as active.

When was JAZZ PHARMACEUTICALS RESEARCH UK LIMITED incorporated?

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED was incorporated on 28 September 1995, according to Companies House.

What is JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's registered address?

The registered address on file for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED is Sittingbourne, United Kingdom.

What legal structure is JAZZ PHARMACEUTICALS RESEARCH UK LIMITED registered as?

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED is registered as a Private limited company (Ltd.) in United Kingdom.

Who are the officers/directors of JAZZ PHARMACEUTICALS RESEARCH UK LIMITED?

Four officers are currently on record for JAZZ PHARMACEUTICALS RESEARCH UK LIMITED, filed with Companies House. David Spackman (appointed 2023-01-13), Luca Marchetti (appointed 2023-04-28) and Jessica Petersen (appointed 2024-10-01) all serve as Director; Alkesh Patel (appointed 2024-04-03) serves as Company Secretary. Management authority at JAZZ PHARMACEUTICALS RESEARCH UK LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does JAZZ PHARMACEUTICALS RESEARCH UK LIMITED have a parent company or subsidiaries?

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED sits 3 levels below its ultimate parent, JAZZ INVESTMENTS EUROPE LIMITED, registered in Malta.

Can Zavia monitor changes to JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's ownership over time?

This profile reflects a point-in-time snapshot from Companies House. Zavia's monitoring API can track changes to JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United Kingdom, so records like JAZZ PHARMACEUTICALS RESEARCH UK LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Companies House and was last synced on 19 October 2026.

This website uses cookies to improve your web experience.